What is Clinical Research Stakeholders

Racially and ethnically diverse populations are underrepresented as participants in clinical trials. The disproportionate impact COVID-19 has on communities of color intensifies the imperativeness of equitable access. The purpose of this chapter is to explore how clinical research stakeholders can adapt their traditional approaches to recruitment, research conduct, and design sparked by the current healthcare crisis through technology-oriented strategies designed to increase diverse representation in clinical trials. Strategies utilizing technology will be recommended by examining this issue from a centralized and local perspective across a patient's journey in a clinical trial, with a specific focus on fostering long-term, trusting community relationships. Technology-oriented strategies including health information technology and digital media may provide promising solutions for improving clinical trial diversity amid a transitioning environment that is already adapting to virtual methods for communicating and engaging with patients regarding clinical research.